MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

PULM — Pulmatrix, Inc. Common Stock

Nasdaq

Pulmatrix, Inc. Common Stock

CompareBack to Screener
$1.49
+0.06(+4.20%)
O
1.46
H
1.51
L
1.43
V
11.75K
⏱️ End-of-day dataAs of Oct 7, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About PULM

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMar 21, 2014
Employees2
Stock ExchangeNasdaq
Ticker SymbolPULM
Websitehttps://www.pulmatrix.com

Key Financial Statistics

Market Cap$5.73M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.16 - $5.24
52-Week Avg Volume35.3K
VWAP$1.46
Transactions150
Total Recorded Bars3,157 days